Subsets of CTCs expressing cell surface markers EpCAM, CD44, CD47 and c-Met were capable of initiating metastases in animal models [46] and hence, these seminal findings might pave the way for novel strategies in cancer therapy because potential targets of therapy, both cellular and molecular, become apparent (Figure 3). The gene discussed is MET; the disease is cancer.